NCT06247501
- Conditions
- CD19 CAR-T Therapy, Very High Risk Acute Lymphoblastic Leukemia
- Locations
-
- Seoul National University Children's Hospital Seoul, South Korea
Clinical trial condition
Explore clinical trials studying CD19 CAR-T Therapy. Study availability and eligibility vary by location and protocol.
NCT06247501